跳至主要内容
临床试验/NCT01739673
NCT01739673已完成不适用

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Cxlusa7 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2011年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Cxlusa
入组人数
13
试验地点
7
主要终点
Resolution of Signs and Symptoms of Infectious Keratitis

研究概览

简要总结

This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must be 18 years of age or older.
  • Ability to provide written informed consent.
  • Likely to complete all study visits.
  • Subjects must have one eye that with a diagnosis of infectious keratitis.

排除标准

  • A corneal perforation.
  • Descemetocele.
  • Pregnancy or breastfeeding.
  • Active Herpes corneal disease.
  • Patient is unwilling or unable to comply with a medication regimen and follow up appointments.

结局指标

主要结局

Resolution of Signs and Symptoms of Infectious Keratitis

时间窗: Subjects will be followed until resolution of signs and symptoms, an expected average of 8 weeks

次要结局

未报告次要终点

研究者

发起方
Cxlusa
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验